2-[2-(3-fluorophenyl)-7-methyl-4-oxo-3-pyrrol-1-ylpyrazolo[3,4-d]pyridazin-5-yl]-N-(2-morpholin-4-ylethyl)acetamide

C24H26FN7O3 — CID 46350323

IUPAC2-[2-(3-fluorophenyl)-7-methyl-4-oxo-3-pyrrol-1-ylpyrazolo[3,4-d]pyridazin-5-yl]-N-(2-morpholin-4-ylethyl)acetamide
SMILESCc1nn(CC(=O)NCCN2CCOCC2)c(=O)c2c(-n3cccc3)n(-c3cccc(F)c3)nc12
InChIInChI=1S/C24H26FN7O3/c1-17-22-21(23(30-8-2-3-9-30)32(28-22)19-6-4-5-18(25)15-19)24(34)31(27-17)16-20(33)26-7-10-29-11-13-35-14-12-29/h2-6,8-9,15H,7,10-14,16H2,1H3,(H,26,33)
InChIKeyNVGBFERMODAEIO-UHFFFAOYSA-N
MW479.52 g/mol
LogP1.27
Rot. Bonds7

About 2-[2-(3-fluorophenyl)-7-methyl-4-oxo-3-pyrrol-1-ylpyrazolo[3,4-d]pyridazin-5-yl]-N-(2-morpholin-4-ylethyl)acetamide

2-[2-(3-fluorophenyl)-7-methyl-4-oxo-3-pyrrol-1-ylpyrazolo[3,4-d]pyridazin-5-yl]-N-(2-morpholin-4-ylethyl)acetamide (PubChem CID 46350323) has the molecular formula C24H26FN7O3 and a molecular weight of 479.52 g/mol. Its IUPAC name is 2-[2-(3-fluorophenyl)-7-methyl-4-oxo-3-pyrrol-1-ylpyrazolo[3,4-d]pyridazin-5-yl]-N-(2-morpholin-4-ylethyl)acetamide.

Molecular Properties

Compound Name2-[2-(3-fluorophenyl)-7-methyl-4-oxo-3-pyrrol-1-ylpyrazolo[3,4-d]pyridazin-5-yl]-N-(2-morpholin-4-ylethyl)acetamide
PubChem CID46350323
Molecular FormulaC24H26FN7O3
Molecular Weight479.52 g/mol
Exact Mass479.21
IUPAC Name2-[2-(3-fluorophenyl)-7-methyl-4-oxo-3-pyrrol-1-ylpyrazolo[3,4-d]pyridazin-5-yl]-N-(2-morpholin-4-ylethyl)acetamide
SMILESCc1nn(CC(=O)NCCN2CCOCC2)c(=O)c2c(-n3cccc3)n(-c3cccc(F)c3)nc12
InChIInChI=1S/C24H26FN7O3/c1-17-22-21(23(30-8-2-3-9-30)32(28-22)19-6-4-5-18(25)15-19)24(34)31(27-17)16-20(33)26-7-10-29-11-13-35-14-12-29/h2-6,8-9,15H,7,10-14,16H2,1H3,(H,26,33)
InChIKeyNVGBFERMODAEIO-UHFFFAOYSA-N
XLogP1.27
TPSA99.21 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms35
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500479.52
LogP ≤ 51.27
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Analyze 2-[2-(3-fluorophenyl)-7-methyl-4-oxo-3-pyrrol-1-ylpyrazolo[3,4-d]pyridazin-5-yl]-N-(2-morpholin-4-ylethyl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[2-(3-fluorophenyl)-7-methyl-4-oxo-3-pyrrol-1-ylpyrazolo[3,4-d]pyridazin-5-yl]-N-(2-morpholin-4-ylethyl)acetamide?
The IUPAC name of 2-[2-(3-fluorophenyl)-7-methyl-4-oxo-3-pyrrol-1-ylpyrazolo[3,4-d]pyridazin-5-yl]-N-(2-morpholin-4-ylethyl)acetamide (CID 46350323) is 2-[2-(3-fluorophenyl)-7-methyl-4-oxo-3-pyrrol-1-ylpyrazolo[3,4-d]pyridazin-5-yl]-N-(2-morpholin-4-ylethyl)acetamide.
What is the SMILES notation for 2-[2-(3-fluorophenyl)-7-methyl-4-oxo-3-pyrrol-1-ylpyrazolo[3,4-d]pyridazin-5-yl]-N-(2-morpholin-4-ylethyl)acetamide?
The canonical SMILES for 2-[2-(3-fluorophenyl)-7-methyl-4-oxo-3-pyrrol-1-ylpyrazolo[3,4-d]pyridazin-5-yl]-N-(2-morpholin-4-ylethyl)acetamide is Cc1nn(CC(=O)NCCN2CCOCC2)c(=O)c2c(-n3cccc3)n(-c3cccc(F)c3)nc12.
What is the InChIKey of 2-[2-(3-fluorophenyl)-7-methyl-4-oxo-3-pyrrol-1-ylpyrazolo[3,4-d]pyridazin-5-yl]-N-(2-morpholin-4-ylethyl)acetamide?
The InChIKey is NVGBFERMODAEIO-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H26FN7O3/c1-17-22-21(23(30-8-2-3-9-30)32(28-22)19-6-4-5-18(25)15-19)24(34)31(27-17)16-20(33)26-7-10-29-11-13-35-14-12-29/h2-6,8-9,15H,7,10-14,16H2,1H3,(H,26,33).
What are the key properties of 2-[2-(3-fluorophenyl)-7-methyl-4-oxo-3-pyrrol-1-ylpyrazolo[3,4-d]pyridazin-5-yl]-N-(2-morpholin-4-ylethyl)acetamide?
2-[2-(3-fluorophenyl)-7-methyl-4-oxo-3-pyrrol-1-ylpyrazolo[3,4-d]pyridazin-5-yl]-N-(2-morpholin-4-ylethyl)acetamide has a molecular weight of 479.52 g/mol, XLogP of 1.27, 7 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-(3-fluorophenyl)-7-methyl-4-oxo-3-pyrrol-1-ylpyrazolo[3,4-d]pyridazin-5-yl]-N-(2-morpholin-4-ylethyl)acetamide is sourced from PubChem (CID 46350323), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).